Atypical cystic lobules: An early stage in the formation of low-grade ductal carcinoma in situ

Virchows Archiv

Volumn 435, Issue 4, 1999, Pages 413-421

  Oyama, Tetsunari ^a,b   Maluf, Horacio ^c   Koerner, Frederick ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b GUNMA UNIVERSITY   (Japan)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atypical ductal hyperplasia; Cyclin D1; Ductal carcinoma in situ; Estrogen receptor; Keratin 19

Indexed keywords

CYCLIN D1; CYTOKERATIN 19; HORMONE RECEPTOR;

ARTICLE; BREAST CARCINOGENESIS; BREAST CYST; CANCER STAGING; CARCINOMA IN SITU; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; PRIORITY JOURNAL;

BILE DUCT NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CYSTIC DUCT; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PRECANCEROUS CONDITIONS;

EID: 0032847233     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280050419     Document Type: Article

References (39)

1. Azzopardi JG (1979) Problems in breast pathology. Saunders, Philadelphia
2. Bartek J, Taylor-Papadimitriou J, Miller N, Millis R (1985) Patterns of expression of keratin 19 as detected with monoclonal antibodies in human breast tissues and tumours. Int J Cancer 36:299-306
3. Bloodgood JC (1906) Senile parenchymatous hypertrophy of female breast. Its relation to cyst formation and carcinoma. Surg Gynecol Obstet 3:721-730
4. Bodian CA, Perzin KH, Lattes R, Hoffmann P, Abernathy TG (1993) Prognostic significance of benign proliferative breast disease. Cancer 71:3896-3907
5. Broders AC (1932) Carcinoma in situ contrasted with benign penetrating epithelium. JAMA 99:1670-1674
6. Bur ME, Zimarowski MJ, Schnitt SJ, Baker S, Lew R (1992) Estrogen receptor immunohistochemistry in carcinoma in situ of the breast. Cancer 69:1174-1181
7. Cheatle GL (1920) Cysts, and primary cancer in cysts, of the breast. Br J Surg 8:149-166
8. Cheatle GL, Cutler M (1931) Tumors of the breast. Their pathology, symptoms, diagnosis, and treatment, Chap IX. Malignant epithelial neoplasia. Lippincott, Philadelphia, 1931
9. De Potter CR, Foschini MP, Schelfhout A-M, Schroeter CA, Eusebi V (1993) Immunohistochemical study of neu protein overexpression in clinging in situ duct carcinoma of the breast. Virchows Arch [A] 422:375-380
10. Eusebi V, Forchini MP, Cook MG, Berrino F, Azzopardi JG (1989) Long-term follow-up of in situ carcinoma of the breast with special emphasis on clinging carcinoma. Semin Diagn Pathol 6:165-173
11. Eusebi V, Feudale E, Foschini MP, Micheli A, Conti A, Riva C, Di Palma S, Rilke F (1994) Long-term follow-up of in situ carcinoma of the breast. Semin Diagn Pathol 11:223-235
12. Fraser JL, Raza S, Chorny K, Connolly JL, Schnitt SJ (1998) Columnar alteration with prominent apical snouts and secretions. A spectrum of changes frequently present in breast biopsies performed for microcalcifications. Am J Surg Pathol 22:1521-1527
13. Gillett CE, Lee AHS, Millis RR, Barnes DM (1998) Cyclin D1 and associated proteins in mammary ductal carcinoma in situ and atypical ductal hyperplasia. J Pathol 184:396-400
14. Goldberg DE, Stuart J, Koerner FC (1994) Progesterone receptor detection in paraffin sections of human breast cancers by an immunoperoxidase technique incorporating microwave heating. Mod Pathol 7:401-406
15. Goldstein NS, O'Malley BA (1997) Cancerization of small ectatic ducts of the breast by ductal carcinoma in situ cells with apocrine snouts. A lesion associated with tubular carcinoma. Am J Clin Pathol 107:561-566
16. Hoshi K, Mochizuki M, Otaka T, Wakasa H (1991) Stereomicroscopic study of atypical lobules in low papillary carcinomas. (Proceeding of the Japanese Cancer Association 50th Annual Meeting, Tokyo) Jpn J Cancer Res [Suppl] 1991:321
17. Hsu SM, Raine L, Fanger H (1981) Use of avidin-biotin complex (ABC) in immunoperoxidase techniques: comparison between ABC and unlabelled antibody (PAP) procedure. J Histochem Cytochem 29:577-580
18. Koerner FC, Goldberg DE, Edgerton SE, Schwartz LH (1992) pS2 protein and steroid hormone receptors in invasive breast carcinomas. Int J Cancer 52:183-188
19. Kuroda H, Komatsu H, Nakamura S, Niitsu Y, Takahashi T, Ueda R, et al (1995) The positive nuclear staining observed with monoclonal antibody against PRAD1/cyclin Dl correlates with RNA expression in mantle cell lymphoma. Jpn J Cancer Res 86:890-898
20. Lakhani SR, Collins N, Stratton MR, Sloane JP (1995) Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p. J Clin Pathol 48:611-615
21. London SJ, Connolly JL, Schnitt SJ, Colditz G A (1992) A prospective study of benign breast disease and the risk of breast cancer. JAMA 267:941-944
22. MacCarty WC (1913) The histogenesis of cancer (carcinoma) of the breast and its clinical significance. Surg Gynecol Obstet 17:441-459
23. McDivitt RW, Stevens JA, Lee NC, Wingo PA, Rubin GL, Gersell D, Cancer and Steroid Hormone Study Group (1992) Histologic types of benign breast disease and the risk for breast cancer. Cancer 69:1408-1414
24. Nakamura S, Seto M, Banno S, Suzuki S, Koshikawa T, Kitoh K, et al. (1994) Immunohistochemical analysis of cyclin Dl protein in hematopoietic neoplasms with special reference to mantle cell lymphoma. Jpn J Cancer Res 85:1270-1279
25. P, Pekkel V, Fuqua SAW, Osborne CK, Clark GM, Allred DC (1998) Analysis of loss of heterozygosity in 199 premalignant breast lesions at 15 genetic loci. J Natl Cancer Inst 90:697-703
26. Page DL, Anderson TJ (1987) Diagnostic histopathology of the breast. Churchill Livingstone, New York
27. Page DL, Dupont WD, Rogers LW, Rados MS (1985) Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 55:2698-2708
28. Rosen PP, Oberman HA (1992) Tumors of the mammary gland. (Atlas of tumor pathology, 3rd ser, fasc 7) Armed Forces Institute of Pathology, Washington, DC
29. Rosenberg CL, Larson PS, Romo JD, de las Morenas A, Faller DV (1997) Microsatellite alterations indicating monoclonality in atypical hyerplasia associated with breast cancer. Hum Pathol 28:214-219
30. Russo J, Russo IH (1987) Development of the human mammary gland. In: Neville MC, Daniel CW (eds) The mammary gland. Plenum Press, New York
31. Sasse F (1897) Über Cysten und cystiche Tumoren der Mamma. Arch fur Klin Chir 54:1-54
32. Schimmelbusch G (1892) Das Cystadenom der Mamma. Arch Klin Chir 44:117-134
33. Sloane JP, Trott PA (1985) Biopsy pathology of the breast. Wiley, New York
34. Tavassoli FA (1998) Ductal carcinoma in situ: introduction of the concept of ductal intraepithelial neoplasia. Mod Pathol 11:140-154
35. Tavassoli FA, Norris HJ (1990) A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast Cancer 65:518-529
36. Tsuchiya S (1998) Atypical ductal hyperplasia, atypical lobular hyperplasia, and interpretation of a new borderline lesion. Jpn J Cancer Clin 44:548-555
37. Warren JC (1905) The surgeon and the pathologist. A plea for reciprocity as illustrated by the consideration of the classification and treatment of benign tumors of the breast. JAMA 45:149-165
38. Wellings SR, Jensen HM, Marcum RG (1975) An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst 55:231-263
39. Zafrani B, Leroyer A, Fourquet A, Laurent M, Trophilme D, Validire P, Sastre-Garau X (1994) Mammographically-detected ductal in situ carcinoma of the breast analyzed with a new classification. A study of 127 cases: correlation with estrogen and progesterone receptors, p53, and c-erbB-2 proteins, and proliferative activity. Semin Diagn Pathol 11:208-214